ArticleTheranostics2024

Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.

Wenyi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.